- Home
- JANX vs HBI Comparison
JANX vs HBI Comparison
Compare JANX & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- HBI
- Stock Information
- Founded
- JANX 2017
- HBI 1901
- Country
- JANX United States
- HBI United States
- Employees
- JANX N/A
- HBI N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- HBI Clothing/Shoe/Accessory Stores
- Sector
- JANX Health Care
- HBI Consumer Discretionary
- Exchange
- JANX Nasdaq
- HBI Nasdaq
- Market Cap
- JANX 2.9B
- HBI 2.5B
- IPO Year
- JANX 2021
- HBI 2006
- Fundamental
- Price
- JANX $46.50
- HBI $8.19
- Analyst Decision
- JANX Strong Buy
- HBI Hold
- Analyst Count
- JANX 10
- HBI 5
- Target Price
- JANX $65.10
- HBI $6.00
- AVG Volume (30 Days)
- JANX 637.5K
- HBI 6.5M
- Earning Date
- JANX 11-06-2024
- HBI 11-07-2024
- Dividend Yield
- JANX N/A
- HBI N/A
- EPS Growth
- JANX N/A
- HBI N/A
- EPS
- JANX N/A
- HBI N/A
- Revenue
- JANX $13,049,000.00
- HBI $5,466,904,000.00
- Revenue This Year
- JANX $66.30
- HBI N/A
- Revenue Next Year
- JANX N/A
- HBI $0.22
- P/E Ratio
- JANX N/A
- HBI N/A
- Revenue Growth
- JANX 54.12
- HBI 25.57
- 52 Week Low
- JANX $7.79
- HBI $3.58
- 52 Week High
- JANX $65.60
- HBI $8.70
- Technical
- Relative Strength Index (RSI)
- JANX 33.84
- HBI 61.17
- Support Level
- JANX $47.04
- HBI $6.98
- Resistance Level
- JANX $49.74
- HBI $8.60
- Average True Range (ATR)
- JANX 2.88
- HBI 0.41
- MACD
- JANX -1.00
- HBI 0.05
- Stochastic Oscillator
- JANX 4.54
- HBI 70.06
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated as it produces more than 70% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina.